Racura Oncology Ltd Stock: price and insider trades · Australia
1 insider bought €28k of shares over the last 90 days, the latest by Daniel Tillett, filed 29 Sept 2026.
Racura Oncology Ltd: what insiders have been doing
This page follows insider dealings at Racura Oncology Ltd as filed with ASX. Over the twelve months to 18 October 2026, 8 filings were filed, from 2 insiders.
Not one open-market sale was filed. On the buying side, 2 insiders reported 2 purchases totalling €47k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Daniel Tillett filed the largest purchase, €28k, on 29 September 2026, which represents 0.012% of the company's market value. The buyers include 2 senior executives.
The most recent open-market purchase was published on 29 September 2026, 40 days ago. Publication is fast: at least half of the trades appear on ASX on the same day. The shorter that gap, the sooner other investors can see what insiders have done.
For context, the typical company on the same exchange (median of 1,605 companies) published 4 filings over the same period, against 8 filings here. Our records for Racura Oncology Ltd go back to 2026, with 2 purchases and no sales on the open market in total.
Source: insider filings from ASX. Past trades are no guide to future returns.
Who traded when
BuySaleThis score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2026FY ended June 2026 · cache
- 2 shares@ A$22,850.7750.012% mcap2.7% of flowShareASXASX:2924-03141443-2A1700272Canonical exit: 28 Dec 2026 (T+90)
- 0@ A$351,882.950.088% mcap21.3% of flowShareASXASX:2924-03138501-2A1698554
- ▲Executives30,375 AUD0ASX
- 0@ A$1.25100.0% of flowShareASXISIN AU000000RAC3ASX:2924-03094709-2A1674266
- 0@ A$1.250.12% mcap30.0% of flowShareASXASX:2924-03093792-2A1673848
- 0@ A$1.250.075% mcap18.6% of flowShareASXASX:2924-03092476-2A1673192
- 0@ A$1.250.061% mcap15.1% of flowShareASXASX:2924-03090133-2A1672089
- 0@ A$1.250.061% mcap15.0% of flowShareASXASX:2924-03087778-2A1670871
8 of 8 declarations
About Racura Oncology Ltd
Racura Oncology Ltd is a company focused on developing innovative cancer treatments. It is listed on the XASX market.